1887

Abstract

Antimicrobial resistance (AMR) is a global threat, including in sub-Saharan Africa. However, little is known about the genetics of resistant bacteria in the region. In Malawi, there is growing concern about increasing rates of antimicrobial resistance to most empirically used antimicrobials. The highly drug resistant sequence type (ST) 131, which is associated with the extended spectrum β-lactamase , has been increasing in prevalence globally. Previous data from isolates collected between 2006 and 2013 in southern Malawi have revealed the presence of ST131 and the gene in the country. We performed whole genome sequencing (WGS) of 58 clinical isolates at Kamuzu Central Hospital, a tertiary care centre in central Malawi, collected from 2012 to 2018. We used Oxford Nanopore Technologies (ONT) sequencing, which was performed in Malawi. We show that ST131 is observed more often (14.9% increasing to 32.8%) and that the gene is occurring at a higher frequency (21.3% increasing to 44.8%). Phylogenetics indicates that isolates are highly related between the central and southern geographic regions and confirms that ST131 isolates are contained in a single group. All AMR genes, including , were widely distributed across sequence types. We also identified an increased number of ST410 isolates, which in this study tend to carry a plasmid-located copy of gene at a higher frequency than occurs in ST131. This study confirms the expanding nature of ST131 and the wide distribution of the gene in Malawi. We also highlight the feasibility of conducting longitudinal genomic epidemiology studies of important bacteria with the sequencing done on site using a nanopore platform that requires minimal infrastructure.

  • This is an open-access article distributed under the terms of the Creative Commons Attribution License.
Loading

Article metrics loading...

/content/journal/mgen/10.1099/mgen.0.000490
2020-12-09
2024-04-20
Loading full text...

Full text loading...

/deliver/fulltext/mgen/7/1/mgen000490.html?itemId=/content/journal/mgen/10.1099/mgen.0.000490&mimeType=html&fmt=ahah

References

  1. Prestinaci F, Pezzotti P, Pantosti A. Antimicrobial resistance: a global multifaceted phenomenon. Pathog Glob Health 2015; 109:309–318 [View Article][PubMed]
    [Google Scholar]
  2. WHO WHO publishes list of bacteria for which new antibiotics are urgently needed. http://www.who.int/mediacentre/news/releases/2017/bacteria-antibiotics-needed/en/ (accessed 3 March 2020).
  3. Hill PC, Onyeama CO, Ikumapayi UNA, Secka O, Ameyaw S et al. Bacteraemia in patients admitted to an urban hospital in West Africa. BMC Infect Dis 2007; 7: [View Article]
    [Google Scholar]
  4. Okomo UA, Garba D, Fombah AE, Secka O, Ikumapayi UNA et al. Bacterial isolates and antibiotic sensitivity among Gambian children with severe acute malnutrition. Int J Pediatr 2011; 2011:8251238 [View Article][PubMed]
    [Google Scholar]
  5. Nielsen MV, Sarpong N, Krumkamp R, Dekker D, Loag W et al. Incidence and characteristics of bacteremia among children in rural Ghana. PLoS One 2012; 7:e44063 [View Article][PubMed]
    [Google Scholar]
  6. Enweronu-Laryea CC, Newman MJ. Changing pattern of bacterial isolates and antimicrobial susceptibility in neonatal infections in Korle BU teaching Hospital, Ghana. East Afr Med J 2007; 84:136–140 [View Article][PubMed]
    [Google Scholar]
  7. Samuel SO, Fadeyi A, Akanbi AA, Ameen NB, Nwabuisi C et al. Bacterial isolates of blood cultures in patients with suspected septicaemia in Ilorin, Nigeria. Afr J Med Med Sci 2006; 35:137–141[PubMed]
    [Google Scholar]
  8. Popoola O, Kehinde A, Ogunleye V, Adewusi OJ, Toy T et al. Bacteremia among febrile patients attending selected healthcare facilities in Ibadan, Nigeria. Clin Infect Dis 2019; 69:S466–S473 [View Article][PubMed]
    [Google Scholar]
  9. Poolman JT, Wacker M. Extraintestinal pathogenic Escherichia coli, a common human pathogen: challenges for vaccine development and progress in the field. J Infect Dis 2016; 213:6–13 [View Article][PubMed]
    [Google Scholar]
  10. Decano AG, Downing T. An Escherichia coli ST131 pangenome atlas reveals population structure and evolution across 4,071 isolates. Sci Rep 2019; 9:17394 [View Article][PubMed]
    [Google Scholar]
  11. Ludden C, Decano AG, Jamrozy D, Pickard D, Morris D et al. Genomic surveillance of Escherichia coli ST131 identifies local expansion and serial replacement of subclones. Microb Genom 2020; 6: [View Article]
    [Google Scholar]
  12. Banerjee R, Johnson JR. A new clone sweeps clean: the enigmatic emergence of Escherichia coli sequence type 131. Antimicrob Agents Chemother 2014; 58:4997–5004 [View Article][PubMed]
    [Google Scholar]
  13. Findlay J, Gould VC, North P, Bowker KE, Martin Williams O et al. Characterisation of cefotaxime-resistant urinary Escherichia coli from primary care in south-west England. 2017–2018
  14. Chaudhuri RR, Henderson IR. The evolution of the Escherichia coli phylogeny. Infect Genet Evol 2012; 12:214–226 [View Article][PubMed]
    [Google Scholar]
  15. D'Andrea MM, Arena F, Pallecchi L, Rossolini GM. CTX-M-Type β-lactamases: a successful story of antibiotic resistance. Int J Med Microbiol 2013; 303:305–317 [View Article][PubMed]
    [Google Scholar]
  16. Peirano G, Richardson D, Nigrin J, McGeer A, Loo V et al. High prevalence of ST131 isolates producing CTX-M-15 and CTX-M-14 among extended-spectrum-β-lactamase-producing Escherichia coli isolates from Canada. Antimicrob Agents Chemother 2010; 54:1327–1330 [View Article][PubMed]
    [Google Scholar]
  17. Peirano G, Costello M, Pitout JDD. Molecular characteristics of extended-spectrum β-lactamase-producing Escherichia coli from the Chicago area: high prevalence of ST131 producing CTX-M-15 in community hospitals. Int J Antimicrob Agents 2010; 36:19–23 [View Article][PubMed]
    [Google Scholar]
  18. Kanamori H, Parobek CM, Juliano JJ, Johnson JR, Johnston BD et al. Genomic analysis of multidrug-resistant Escherichia coli from North Carolina community hospitals: ongoing circulation of CTX-M-Producing ST131-H30Rx and ST131-H30R1 strains. Antimicrob Agents Chemother 2017; 61: 25 07 2017 [View Article][PubMed]
    [Google Scholar]
  19. Matsumura Y, Pitout JDD, Peirano G, DeVinney R, Noguchi T et al. Rapid identification of different Escherichia coli sequence type 131 clades. Antimicrob Agents Chemother 2017; 61: 25 07 2017 [View Article][PubMed]
    [Google Scholar]
  20. Cantón R, González-Alba JM, Galán JC. CTX-M enzymes: origin and diffusion. Front Microbiol 2012; 3:110 [View Article][PubMed]
    [Google Scholar]
  21. Irenge LM, Ambroise J, Bearzatto B, Durant J-F, Chirimwami RB et al. Whole-genome sequences of multidrug-resistant Escherichia coli in South-Kivu Province, Democratic Republic of Congo: characterization of phylogenomic changes, virulence and resistance genes. BMC Infect Dis 2019; 19:137 [View Article][PubMed]
    [Google Scholar]
  22. Sonda T, Kumburu H, van Zwetselaar M, Alifrangis M, Mmbaga BT et al. Whole genome sequencing reveals high clonal diversity of Escherichia coli isolated from patients in a tertiary care hospital in Moshi, Tanzania. Antimicrob Resist Infect Control 2018; 7:72 [View Article][PubMed]
    [Google Scholar]
  23. Ingle DJ, Levine MM, Kotloff KL, Holt KE, Robins-Browne RM. Dynamics of antimicrobial resistance in intestinal Escherichia coli from children in community settings in South Asia and sub-Saharan Africa. Nat Microbiol 2018; 3:1063–1073 [View Article][PubMed]
    [Google Scholar]
  24. Mbelle NM, Feldman C, Osei Sekyere J, Maningi NE, Modipane L et al. The resistome, mobilome, virulome and phylogenomics of multidrug-resistant Escherichia coli clinical isolates from Pretoria, South Africa. Sci Rep 2019; 9:16457 [View Article][PubMed]
    [Google Scholar]
  25. Iroh Tam P-Y, Musicha P, Kawaza K, Cornick J, Denis B et al. Emerging resistance to empiric antimicrobial regimens for pediatric bloodstream infections in Malawi (1998-2017). Clin Infect Dis 2019; 69:61–68 [View Article][PubMed]
    [Google Scholar]
  26. Haigh K, Dube Q, Kasambara W, Feasey NA, Lester R. Cephalosporin resistance in Malawi. Lancet Infect Dis 2020; 20:285–286 [View Article][PubMed]
    [Google Scholar]
  27. Musicha P, Feasey NA, Cain AK, Kallonen T, Chaguza C et al. Genomic landscape of extended-spectrum β-lactamase resistance in Escherichia coli from an urban African setting. J Antimicrob Chemother 2017; 72:1602–1609 [View Article][PubMed]
    [Google Scholar]
  28. Clinical and Laboratory Standards Institute M100 Performance Standards for Antimicrobial Susceptibility Testing. https://clsi.org/media/2663/m100ed29_sample.pdf (accessed 9 May 2020).
  29. nanoporetech nanoporetech/flappie. GitHub. https://github.com/nanoporetech/flappie (accessed 3 March 2020).
  30. Kolmogorov M, Yuan J, Lin Y, Pevzner PA. Assembly of long, error-prone reads using repeat graphs. Nat Biotechnol 2019; 37:540–546 [View Article]
    [Google Scholar]
  31. Wick RR, Holt KE. Benchmarking of long-read assemblers for prokaryote whole genome sequencing. F1000Res 2019; 8:2138 [View Article][PubMed]
    [Google Scholar]
  32. Tvedte ES, Gasser M, Sparklin BC, Michalski J, Zhao X et al. Comparison of long read sequencing technologies in resolving bacteria and fly genomes.
  33. Vaser R, Sović I, Nagarajan N, Šikić M. Fast and accurate de novo genome assembly from long uncorrected reads. Genome Res 2017; 27:737–746 [View Article][PubMed]
    [Google Scholar]
  34. Website Medaka: sequence correction provided by ONT research. https://github.com/nanoporetech/medaka 3 March 2020
  35. Inouye M, Dashnow H, Raven L-A, Schultz MB, Pope BJ et al. SRST2: rapid genomic surveillance for public health and hospital microbiology labs. Genome Med 2014; 6:90 [View Article][PubMed]
    [Google Scholar]
  36. Gonzalez-Escalona N, Allard MA, Brown EW, Sharma S, Hoffmann M. Nanopore sequencing for fast determination of plasmids, phages, virulence markers, and antimicrobial resistance genes in Shiga toxin-producing Escherichia coli .
  37. Mohsin M, Raza S, Schaufler K, Roschanski N, Sarwar F et al. High prevalence of CTX-M-15-Type ESBL-producing E. coli from migratory avian species in Pakistan. Front Microbiol 2017; 8:2476 [View Article][PubMed]
    [Google Scholar]
  38. Shropshire WC, Aitken SL, Pifer R, Kim J, Bhatti MM et al. Concurrence of porin loss and modular amplification of β-lactamase encoding genes drives carbapenem resistance in a cohort of recurrent Enterobacterales bacteremia. BioRxiv
    [Google Scholar]
  39. Li H. Minimap2: pairwise alignment for nucleotide sequences. Bioinformatics 2018; 34:3094–3100 [View Article][PubMed]
    [Google Scholar]
  40. Naidenov B, Lim A, Willyerd K, Torres NJ, Johnson WL et al. Pan-genomic and polymorphic driven prediction of antibiotic resistance in Elizabethkingia . Front Microbiol 2019; 10:1446 [View Article][PubMed]
    [Google Scholar]
  41. Edgar RC. MUSCLE: a multiple sequence alignment method with reduced time and space complexity. BMC Bioinformatics 2004; 5:113–119 [View Article]
    [Google Scholar]
  42. Kozlov AM, Darriba D, Flouri T, Morel B, Stamatakis A. RAxML-NG: a fast, scalable and user-friendly tool for maximum likelihood phylogenetic inference. Bioinformatics 2019; 35:4453–4455 [View Article][PubMed]
    [Google Scholar]
  43. Bankevich A, Nurk S, Antipov D, Gurevich AA, Dvorkin M et al. SPAdes: a new genome assembly algorithm and its applications to single-cell sequencing. J Comput Biol 2012; 19:455–477 [View Article][PubMed]
    [Google Scholar]
  44. Page AJ, Cummins CA, Hunt M, Wong VK, Reuter S et al. Roary: rapid large-scale prokaryote pan genome analysis. Bioinformatics 2015; 31:3691–3693 [View Article][PubMed]
    [Google Scholar]
  45. Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc 1995; 57:289–300 [View Article]
    [Google Scholar]
  46. Ministry of Health Malawi National Tuberculosis Control Programme Manual. https://pdf.usaid.gov/pdf_docs/PA00KGDD.pdf (accessed 15 May 2020).
  47. Feehily C, Karatzas KAG. Role of glutamate metabolism in bacterial responses towards acid and other stresses. J Appl Microbiol 2013; 114:11–24 [View Article][PubMed]
    [Google Scholar]
  48. Afset JE, Bruant G, Brousseau R, Harel J, Anderssen E et al. Identification of virulence genes linked with diarrhea due to atypical enteropathogenic Escherichia coli by DNA microarray analysis and PCR. J Clin Microbiol 2006; 44:3703–3711 [View Article][PubMed]
    [Google Scholar]
  49. Binns MM, Mayden J, Levine RP. Further characterization of complement resistance conferred on Escherichia coli by the plasmid genes traT of R100 and iss of ColV,I-K94. Infect Immun 1982; 35:654–659 [View Article][PubMed]
    [Google Scholar]
  50. Binns MM, Davies DL, Hardy KG. Cloned fragments of the plasmid ColV,I-K94 specifying virulence and serum resistance. Nature 1979; 279:778–781 [View Article][PubMed]
    [Google Scholar]
  51. Johnson TJ, Wannemuehler YM, Nolan LK. Evolution of the iss gene in Escherichia coli . Appl Environ Microbiol 2008; 74:2360–2369 [View Article][PubMed]
    [Google Scholar]
  52. Tarr PI, Bilge SS, Vary JC, Jelacic S, Habeeb RL et al. Iha: a novel Escherichia coli O157:H7 adherence-conferring molecule encoded on a recently acquired chromosomal island of conserved structure. Infect Immun 2000; 68:1400–1407 [View Article][PubMed]
    [Google Scholar]
  53. Guyer DM, Radulovic S, Jones F-E, Mobley HLT. Sat, the secreted autotransporter toxin of uropathogenic Escherichia coli, is a vacuolating cytotoxin for bladder and kidney epithelial cells. Infect Immun 2002; 70:4539–4546 [View Article][PubMed]
    [Google Scholar]
  54. Nataro JP, Seriwatana J, Fasano A, Maneval DR, Guers LD et al. Identification and cloning of a novel plasmid-encoded enterotoxin of enteroinvasive Escherichia coli and Shigella strains. Infect Immun 1995; 63:4721–4728 [View Article][PubMed]
    [Google Scholar]
  55. Mao B-H, Chang Y-F, Scaria J, Chang C-C, Chou L-W et al. Identification of Escherichia coli genes associated with urinary tract infections. J Clin Microbiol 2012; 50:449–456 [View Article][PubMed]
    [Google Scholar]
  56. Tyler AD, Mataseje L, Urfano CJ, Schmidt L, Antonation KS et al. Evaluation of Oxford Nanopore’s Minion sequencing device for microbial whole genome sequencing applications. Sci Rep 2018; 8: [View Article]
    [Google Scholar]
  57. Bowden R, Davies RW, Heger A, Pagnamenta AT, de Cesare M et al. Sequencing of human genomes with nanopore technology. Nat Commun 2019; 10:10 [View Article][PubMed]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/mgen/10.1099/mgen.0.000490
Loading
/content/journal/mgen/10.1099/mgen.0.000490
Loading

Data & Media loading...

Supplements

Supplementary material 1

PDF

Supplementary material 2

EXCEL
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error